The global laser capture microdissection market size reached US$ 148.3 Million in 2023. Looking forward, the market is projected to reach US$ 329.3 Million by 2032, exhibiting a growth rate (CAGR) of 9.27% during 2023-2032.
Laser capture microdissection (LCM) is a high-resolution method of isolating cells from their surrounding tissues using a laser beam and direct microscopic visualization. It relies on ultraviolet (UV), infrared, and immunofluorescence laser beams to harvest pure enriched cell populations from tissue, blood, and semen samples. It accurately differentiates between normal and abnormal cells to investigate subcellular profiles.
It is used on formalin-fixed, paraffin wax-embedded, frozen, and cytologic specimens for studying gene expression and detecting cancer. In addition, it finds application in academic and government research institutes, pharmaceutical and biotechnology companies, polymerase chain reaction (PCR), proteomics, and hospitals for next-generation and sanger sequencing.
Besides this, LCM is utilized for establishing genetic fingerprints of specific pathological lesions and malignant neoplasms to identify new diagnostic and prognostic markers. It also helps provide individualized treatment of tumor, which is positively influencing the market. Furthermore, key market players are introducing enhanced LCM technologies equipped with immunofluorescence laser diodes for improved biomarker discovery and cancer chemoprevention, which is projected to bolster the growth of the market.
2. What is the expected growth rate of the global laser capture microdissection market during 2024-2032?
3. What has been the impact of COVID-19 on the global laser capture microdissection market?
4. What are the key factors driving the global laser capture microdissection market?
5. What is the breakup of the global laser capture microdissection market based on the system type?
6. What is the breakup of the global laser capture microdissection market based on the application?
7. What is the breakup of the global laser capture microdissection market based on the end user?
8. What are the key regions in the global laser capture microdissection market?
9. Who are the key players/companies in the global laser capture microdissection market?
Laser capture microdissection (LCM) is a high-resolution method of isolating cells from their surrounding tissues using a laser beam and direct microscopic visualization. It relies on ultraviolet (UV), infrared, and immunofluorescence laser beams to harvest pure enriched cell populations from tissue, blood, and semen samples. It accurately differentiates between normal and abnormal cells to investigate subcellular profiles.
It is used on formalin-fixed, paraffin wax-embedded, frozen, and cytologic specimens for studying gene expression and detecting cancer. In addition, it finds application in academic and government research institutes, pharmaceutical and biotechnology companies, polymerase chain reaction (PCR), proteomics, and hospitals for next-generation and sanger sequencing.
Laser Capture Microdissection Market Trends
The growing utilization of molecular analysis in a bioscience research laboratory, along with the expanding healthcare industry, represents one of the key factors driving the market. Moreover, as LCM allows precise vivo examination of cell populations, such as malignant cells of Hodgkin's disease and carcinoma in situ with sensitive analytical techniques, its sales are rising across the globe. Additionally, there is an increase in healthcare expenditure and research and development (R&D) funding by governments of several countries. This, along with the escalating demand for LCM in forensic science and molecular biology centers to obtain interpretable DNA profiles, is stimulating the market growth.Besides this, LCM is utilized for establishing genetic fingerprints of specific pathological lesions and malignant neoplasms to identify new diagnostic and prognostic markers. It also helps provide individualized treatment of tumor, which is positively influencing the market. Furthermore, key market players are introducing enhanced LCM technologies equipped with immunofluorescence laser diodes for improved biomarker discovery and cancer chemoprevention, which is projected to bolster the growth of the market.
Key Market Segmentation
This report provides an analysis of the key trends in each sub-segment of the global laser capture microdissection market report, along with forecasts at the global, regional and country level from 2024-2032. The report has categorized the market based on product, system type, application and end user.Breakup by Product:
- Instruments
- Consumables
- Software and Services
Breakup by System Type:
- Ultraviolet LCM
- Infrared LCM
- Others
Breakup by Application:
- Research and Development
- Diagnostics
- Others
Breakup by End User:
- Hospitals
- Academic and Government Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape
The competitive landscape of the industry has also been examined along with the profiles of the key players being AnaPath Services GmbH (ST Pharm Co. Ltd), Bio-RAD Laboratories Inc., Caresbio Laboratory LLC, Carl Zeiss Meditec AG (Carl Zeiss AG), Epistem Ltd, Fluidigm Corporation, Gnome Diagnostics LLC, HÜBNER Photonics, Leica Microsystems GmbH (Danaher Corporation), Molecular Machines & Industries, Thermo Fisher Scientific Inc. and VitroVivo Biotech.Key Questions Answered in This Report
1. What was the size of the global laser capture microdissection market in 2023?2. What is the expected growth rate of the global laser capture microdissection market during 2024-2032?
3. What has been the impact of COVID-19 on the global laser capture microdissection market?
4. What are the key factors driving the global laser capture microdissection market?
5. What is the breakup of the global laser capture microdissection market based on the system type?
6. What is the breakup of the global laser capture microdissection market based on the application?
7. What is the breakup of the global laser capture microdissection market based on the end user?
8. What are the key regions in the global laser capture microdissection market?
9. Who are the key players/companies in the global laser capture microdissection market?
Table of Contents
1 Preface3 Executive Summary12 Value Chain Analysis14 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Laser Capture Microdissection Market
6 Market Breakup by Product
7 Market Breakup by System Type
8 Market Breakup by Application
9 Market Breakup by End User
10 Market Breakup by Region
11 SWOT Analysis
13 Porters Five Forces Analysis
15 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- AnaPath Services GmbH (ST Pharm Co. Ltd)
- Bio-RAD Laboratories Inc.
- Caresbio Laboratory LLC
- Carl Zeiss Meditec AG (Carl Zeiss AG)
- Epistem Ltd
- Fluidigm Corporation
- Gnome Diagnostics LLC
- HÜBNER Photonics
- Leica Microsystems GmbH (Danaher Corporation)
- Molecular Machines & Industries
- Thermo Fisher Scientific Inc.
- VitroVivo Biotech
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 136 |
Published | April 2024 |
Forecast Period | 2023 - 2032 |
Estimated Market Value ( USD | $ 148.3 Million |
Forecasted Market Value ( USD | $ 329.3 Million |
Compound Annual Growth Rate | 9.2% |
Regions Covered | Global |
No. of Companies Mentioned | 12 |